We are live on
!
Find out more
KMC
Kirr Marbach & Co Portfolio holdings
AUM
$594M
1-Year Est. Return
34%
This Fund
S&P 500
This Quarter
Est. Return
+1.19%
1 Year Est. Return
+34%
3 Year Est. Return
+134.53%
5 Year Est. Return
+183.29%
10 Year Est. Return
+532.35%
AUM
$461M
AUM Growth
-$16.2M
(-3.4%)
Cap. Flow
-$18.9M
Cap. Flow
% of AUM
-4.1%
Top 10 Holdings %
Top 10 Hldgs %
35.03%
Holding
86
New
3
Increased
2
Reduced
62
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DXC Technology
DXC
|
+$9.25M |
| 2 |
LXFT
Luxoft Holding, Inc.
LXFT
|
+$1.44M |
| 3 |
First Financial Bancorp
FFBC
|
+$514K |
| 4 |
nVent Electric
NVT
|
+$248K |
| 5 |
SHYF
The Shyft Group
SHYF
|
+$78.5K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cognizant
CTSH
|
+$5.33M |
| 2 |
LyondellBasell Industries
LYB
|
+$5.08M |
| 3 |
ILG
ILG, Inc Common Stock
ILG
|
+$4.93M |
| 4 |
Adeia
ADEA
|
+$3.12M |
| 5 |
ICU Medical
ICUI
|
+$604K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 19.57% |
| 2 | Financials | 19.5% |
| 3 | Consumer Discretionary | 12.66% |
| 4 | Technology | 12.51% |
| 5 | Materials | 6.34% |
Similar funds
ESL
BCM
1WCM
LBIM
BWP
SM
DPRC
BBL
Kirr Marbach & Co's Q2 2018 Portfolio in Review
As of Q2 2018, Kirr Marbach & Co held 86 positions worth $461M, down 3.4% from $477M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Kirr Marbach & Co withdrew a net $18.9M in Q2 2018, closing 2 positions and reducing 62 holdings. Its most notable exit was ICU Medical, an estimated $604K position sold in full.
By sector, the portfolio is most concentrated in Industrials at 20% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Kirr Marbach & Co opened a new position in DXC Technology worth $8.68M.
- Kirr Marbach & Co's largest Q2 2018 buy was DXC Technology: 107,655 shares worth $8.68M.
- Kirr Marbach & Co added most to Luxoft Holding, Inc. in Q2 2018, an estimated $1.44M increase.
- Kirr Marbach & Co's biggest Q2 2018 reduction was Cognizant, cutting an estimated $5.33M.
- Kirr Marbach & Co fully exited ICU Medical in Q2 2018, selling an estimated $604K.
- Kirr Marbach & Co's ten largest holdings make up 35% of its $461M portfolio in Q2 2018.
- Kirr Marbach & Co opened 3 new positions and closed 2 in Q2 2018.
- Kirr Marbach & Co's portfolio value fell 3.4% quarter-over-quarter to $461M.
Based on Kirr Marbach & Co's 13F filing for Q2 2018, filed 17 Jul 2018.